1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Sepsis Biomarkers
  • 1.2.3 Antibiotic Resistance Biomarkers
  • 1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
  • 1.2.5 Stroke Testing Biomarkers
  • 1.2.6 Antibiotic Stewardship Biomarkers
  • 1.2.7 Others
• 1.3 Market by Application
  • 1.3.1 Global Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital
  • 1.3.3 Diagnostic Center
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Biomarker Testing Market Perspective (2016-2027)
• 2.2 Biomarker Testing Growth Trends by Regions
  • 2.2.1 Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Biomarker Testing Historic Market Share by Regions (2016-2021)
  • 2.2.3 Biomarker Testing Forecasted Market Size by Regions (2022-2027)
• 2.3 Biomarker Testing Industry Dynamic
  • 2.3.1 Biomarker Testing Market Trends
  • 2.3.2 Biomarker Testing Market Drivers
  • 2.3.3 Biomarker Testing Market Challenges
  • 2.3.4 Biomarker Testing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Biomarker Testing Players by Revenue
  • 3.1.1 Global Top Biomarker Testing Players by Revenue (2016-2021)
  • 3.1.2 Global Biomarker Testing Revenue Market Share by Players (2016-2021)
• 3.2 Global Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Biomarker Testing Revenue
• 3.4 Global Biomarker Testing Market Concentration Ratio
  • 3.4.1 Global Biomarker Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biomarker Testing Revenue in 2020
• 3.5 Biomarker Testing Key Players Head office and Area Served
• 3.6 Key Players Biomarker Testing Product Solution and Service
• 3.7 Date of Enter into Biomarker Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biomarker Testing Breakdown Data by Type

• 4.1 Global Biomarker Testing Historic Market Size by Type (2016-2021)
• 4.2 Global Biomarker Testing Forecasted Market Size by Type (2022-2027)

5 Biomarker Testing Breakdown Data by Application

• 5.1 Global Biomarker Testing Historic Market Size by Application (2016-2021)
• 5.2 Global Biomarker Testing Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Biomarker Testing Market Size (2016-2027)
• 6.2 North America Biomarker Testing Market Size by Type
  • 6.2.1 North America Biomarker Testing Market Size by Type (2016-2021)
  • 6.2.2 North America Biomarker Testing Market Size by Type (2022-2027)
  • 6.2.3 North America Biomarker Testing Market Size by Type (2016-2027)
• 6.3 North America Biomarker Testing Market Size by Application
  • 6.3.1 North America Biomarker Testing Market Size by Application (2016-2021)
  • 6.3.2 North America Biomarker Testing Market Size by Application (2022-2027)
  • 6.3.3 North America Biomarker Testing Market Size by Application (2016-2027)
• 6.4 North America Biomarker Testing Market Size by Country
  • 6.4.1 North America Biomarker Testing Market Size by Country (2016-2021)
  • 6.4.2 North America Biomarker Testing Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Biomarker Testing Market Size (2016-2027)
• 7.2 Europe Biomarker Testing Market Size by Type
  • 7.2.1 Europe Biomarker Testing Market Size by Type (2016-2021)
  • 7.2.2 Europe Biomarker Testing Market Size by Type (2022-2027)
  • 7.2.3 Europe Biomarker Testing Market Size by Type (2016-2027)
• 7.3 Europe Biomarker Testing Market Size by Application
  • 7.3.1 Europe Biomarker Testing Market Size by Application (2016-2021)
  • 7.3.2 Europe Biomarker Testing Market Size by Application (2022-2027)
  • 7.3.3 Europe Biomarker Testing Market Size by Application (2016-2027)
• 7.4 Europe Biomarker Testing Market Size by Country
  • 7.4.1 Europe Biomarker Testing Market Size by Country (2016-2021)
  • 7.4.2 Europe Biomarker Testing Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Biomarker Testing Market Size (2016-2027)
• 8.2 Asia-Pacific Biomarker Testing Market Size by Type
  • 8.2.1 Asia-Pacific Biomarker Testing Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Biomarker Testing Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Biomarker Testing Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Biomarker Testing Market Size by Application
  • 8.3.1 Asia-Pacific Biomarker Testing Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Biomarker Testing Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Biomarker Testing Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Biomarker Testing Market Size by Region
  • 8.4.1 Asia-Pacific Biomarker Testing Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Biomarker Testing Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Biomarker Testing Market Size (2016-2027)
• 9.2 Latin America Biomarker Testing Market Size by Type
  • 9.2.1 Latin America Biomarker Testing Market Size by Type (2016-2021)
  • 9.2.2 Latin America Biomarker Testing Market Size by Type (2022-2027)
  • 9.2.3 Latin America Biomarker Testing Market Size by Type (2016-2027)
• 9.3 Latin America Biomarker Testing Market Size by Application
  • 9.3.1 Latin America Biomarker Testing Market Size by Application (2016-2021)
  • 9.3.2 Latin America Biomarker Testing Market Size by Application (2022-2027)
  • 9.3.3 Latin America Biomarker Testing Market Size by Application (2016-2027)
• 9.4 Latin America Biomarker Testing Market Size by Country
  • 9.4.1 Latin America Biomarker Testing Market Size by Country (2016-2021)
  • 9.4.2 Latin America Biomarker Testing Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Biomarker Testing Market Size (2016-2027)
• 10.2 Middle East & Africa Biomarker Testing Market Size by Type
  • 10.2.1 Middle East & Africa Biomarker Testing Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Biomarker Testing Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Biomarker Testing Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Biomarker Testing Market Size by Application
  • 10.3.1 Middle East & Africa Biomarker Testing Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Biomarker Testing Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Biomarker Testing Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Biomarker Testing Market Size by Country
  • 10.4.1 Middle East & Africa Biomarker Testing Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Biomarker Testing Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Agilent Technologies
  • 11.1.1 Agilent Technologies Company Details
  • 11.1.2 Agilent Technologies Business Overview
  • 11.1.3 Agilent Technologies Biomarker Testing Introduction
  • 11.1.4 Agilent Technologies Revenue in Biomarker Testing Business (2016-2021)
  • 11.1.5 Agilent Technologies Recent Development
• 11.2 Roche
  • 11.2.1 Roche Company Details
  • 11.2.2 Roche Business Overview
  • 11.2.3 Roche Biomarker Testing Introduction
  • 11.2.4 Roche Revenue in Biomarker Testing Business (2016-2021)
  • 11.2.5 Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Biomarker Testing Scope and Market Size
Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Others

Segment by Application
Hospital
Diagnostic Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent Technologies
Roche